44
IRUS Total
Downloads
  Altmetric

The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms

Title: The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms
Authors: Alaggio, R
Amador, C
Anagnostopoulos, I
Attygalle, AD
Araujo, IBDO
Berti, E
Bhagat, G
Borges, AM
Boyer, D
Calaminici, M
Chadburn, A
Chan, JKC
Cheuk, W
Chng, W-J
Choi, JK
Chuang, S-S
Coupland, SE
Czader, M
Dave, SS
De Jong, D
Du, M-Q
Elenitoba-Johnson, KS
Ferry, J
Geyer, J
Gratzinger, D
Guitart, J
Gujral, S
Harris, M
Harrison, CJ
Hartmann, S
Hochhaus, A
Jansen, PM
Karube, K
Kempf, W
Khoury, J
Kimura, H
Klapper, W
Kovach, AE
Kumar, S
Lazar, AJ
Lazzi, S
Leoncini, L
Leung, N
Leventaki, V
Li, X-Q
Lim, MS
Liu, W-P
Louissaint, A
Marcogliese, A
Medeiros, LJ
Michal, M
Miranda, RN
Mitteldorf, C
Montes-Moreno, S
Morice, W
Nardi, V
Naresh, KN
Natkunam, Y
Ng, S-B
Oschlies, I
Ott, G
Parrens, M
Pulitzer, M
Rajkumar, SV
Rawstron, AC
Rech, K
Rosenwald, A
Said, J
Sarkozy, C
Sayed, S
Saygin, C
Schuh, A
Sewell, W
Siebert, R
Sohani, AR
Tooze, R
Traverse-Glehen, A
Vega, F
Vergier, B
Wechalekar, AD
Wood, B
Xerri, L
Xiao, W
Item Type: Journal Article
Abstract: We herein present an overview of the upcoming 5th edition of the World Health Organization Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid and histiocytic neoplasms will be presented in a separate accompanying article. Besides listing the entities of the classification, we highlight and explain changes from the revised 4th edition. These include reorganization of entities by a hierarchical system as is adopted throughout the 5th edition of the WHO classification of tumours of all organ systems, modification of nomenclature for some entities, revision of diagnostic criteria or subtypes, deletion of certain entities, and introduction of new entities, as well as inclusion of tumour-like lesions, mesenchymal lesions specific to lymph node and spleen, and germline predisposition syndromes associated with the lymphoid neoplasms.
Issue Date: 22-Jun-2022
Date of Acceptance: 26-May-2022
URI: http://hdl.handle.net/10044/1/100567
DOI: 10.1038/s41375-022-01620-2
ISSN: 0887-6924
Publisher: Springer Nature [academic journals on nature.com]
Start Page: 1720
End Page: 1748
Journal / Book Title: Leukemia
Volume: 36
Issue: 7
Copyright Statement: © The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Keywords: Science & Technology
Life Sciences & Biomedicine
Oncology
Hematology
ACUTE LYMPHOBLASTIC-LEUKEMIA
T-CELL-LYMPHOMA
CHRONIC LYMPHOCYTIC-LEUKEMIA
PREDOMINANT HODGKIN LYMPHOMA
MULTICENTRIC CASTLEMAN DISEASE
DIFFUSE FOLLICULAR LYMPHOMA
LYMPHOPROLIFERATIVE DISEASE
CLINICOPATHOLOGICAL FEATURES
LYMPHOPLASMACYTIC LYMPHOMA
GENETIC ALTERATIONS
Hematologic Neoplasms
Humans
Lymphoma
World Health Organization
Humans
Lymphoma
Hematologic Neoplasms
World Health Organization
Science & Technology
Life Sciences & Biomedicine
Oncology
Hematology
ACUTE LYMPHOBLASTIC-LEUKEMIA
T-CELL-LYMPHOMA
CHRONIC LYMPHOCYTIC-LEUKEMIA
PREDOMINANT HODGKIN LYMPHOMA
MULTICENTRIC CASTLEMAN DISEASE
DIFFUSE FOLLICULAR LYMPHOMA
LYMPHOPROLIFERATIVE DISEASE
CLINICOPATHOLOGICAL FEATURES
LYMPHOPLASMACYTIC LYMPHOMA
GENETIC ALTERATIONS
Immunology
1103 Clinical Sciences
1112 Oncology and Carcinogenesis
Publication Status: Published
Online Publication Date: 2022-06-22
Appears in Collections:Department of Immunology and Inflammation



This item is licensed under a Creative Commons License Creative Commons